Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.
about
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic managementHost cytokine responses distinguish invasive from airway isolates of the Streptococcus milleri/anginosis group.Clinical significance of microbial infection and adaptation in cystic fibrosis.Effects of extracellular DNA and DNA-binding protein on the development of a Streptococcus intermedius biofilm.Phylogenetic relationship and virulence inference of Streptococcus Anginosus Group: curated annotation and whole-genome comparative analysis support distinct species designationThe development and application of a molecular community profiling strategy to identify polymicrobial bacterial DNA in the whole blood of septic patientsClinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implicationsThe polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture.Molecular pathogenicity of Streptococcus anginosus.Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.Heterologous expression of sahH reveals that biofilm formation is autoinducer-2-independent in Streptococcus sanguinis but is associated with an intact activated methionine cycleThe Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity.Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.The airway microbiome in cystic fibrosis: challenges for therapy
P2860
Q28730299-0D61A38E-19B5-43BB-B410-A43043FA5267Q34246158-AA3E2CE8-B5A6-4615-AC72-D2AC12EA8D90Q34491552-80FE6139-1CCC-4B2D-AAD9-6A5821B5E67FQ34646510-CC3A9627-F650-430D-94EC-4EA5A3283969Q35068178-706B5D4A-9309-4238-8548-F57DA498A1AEQ35810781-AC25D817-41ED-4009-ADD1-700891F9D928Q35864774-B21C932E-B306-4006-B58B-614B5DD1225AQ35987288-2417E457-66AA-4945-A7DC-E60E0BA9633FQ37843465-F0E8E06F-2F4B-4CF5-B770-D2CF7501117DQ38213490-01D09000-27A1-4117-BEA8-00A4D468B69EQ42023933-1A641262-7607-46E6-97CE-3AA947AA16ABQ42108971-792E3386-7245-4490-AF9A-9E2D0A034B38Q42122845-C84DD781-2DC9-4694-AA3C-6A1E794DB605Q46337701-7649D225-253D-4A91-94E7-423746D0A88BQ57913623-DA3D99C2-3608-4E79-A498-F14E601D5196
P2860
Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Characterization of Streptococ ...... patients with cystic fibrosis.
@ast
Characterization of Streptococ ...... patients with cystic fibrosis.
@en
type
label
Characterization of Streptococ ...... patients with cystic fibrosis.
@ast
Characterization of Streptococ ...... patients with cystic fibrosis.
@en
prefLabel
Characterization of Streptococ ...... patients with cystic fibrosis.
@ast
Characterization of Streptococ ...... patients with cystic fibrosis.
@en
P2093
P2860
P356
P1476
Characterization of Streptococ ...... patients with cystic fibrosis.
@en
P2093
Christina S Eshaghurshan
Christopher D Sibley
Harvey R Rabin
Margot E Grinwis
Michael D Parkins
Michael G Surette
P2860
P304
P356
10.1128/JCM.01807-09
P407
P577
2009-12-09T00:00:00Z